Campaign Buzz Obama Romney Vie For Swing Voters

first_imgIn the background, news outlets break down some of the policy specifics in play regarding Medicare and other health issues — and how candidates’ efforts to control the debate are playing among voters.The Wall Street Journal: Romney Targets Obama VotersMitt Romney is putting a new emphasis on visiting counties that voted for President Barack Obama in 2008, as he urges Republicans in swing states to help him push the president’s supporters to switch sides. … As Mr. Romney tweaks his message to appeal to more centrist voters, he must contend with positions he took as he fought for the Republican nomination, such as his vows to defund Planned Parenthood and his plan to restructure Medicare. At one point this year, Mr. Romney told voters that he had been a “severely conservative” governor of Massachusetts (Nelson and O’Connor, 10/9).The New York Times: Obama Campaign Tells Supporters: Steady OnBig Bird was part of a broader effort by Mr. Obama and his team to reassure supporters — many of whom were confident a week ago that the election was all but assured — that his campaign had not lost its intensity or focus. By later in the day, Mr. Obama was delivering a spirited campaign appearance in Columbus, Ohio, his aides were reaching out to big donors with a calming message that they had always expected a tight finish, and the campaign had released new ads in battleground states on issues like potential cuts to Medicaid (Rutenberg and Zeleny, 10/9).And on Medicare policies and how they are playing – CQ HealthBeat: The Medicare ConundrumThe future of Medicare lines up with the economy as one of the hottest topics in this year’s presidential campaign. Republican nominee Mitt Romney accuses President Obama of stealing money from the program to pay for parts of his 2010 health care law. Obama says the GOP plan would “end Medicare as we know it.” … The two men are courting voters 65 and older with essentially the same message: “The other guy wants to change your Medicare. I won’t do that. Vote for me.” In fact, both candidates do want to change Medicare, recognizing that something needs to be done to address the financial crisis facing the half-century-old health care program for the elderly and disabled. At the same time, neither wants to mess with the benefits so dear to the hearts of a demographic group that has a reputation for showing up at the polls (Ethridge, 10/9).The Medicare NewsGroup: Cutting Through The Political Fog: Romney, Ryan, Obama And Medicare’s Fiscal FuturePoliticians and policy specialists alike are debating whether instituting a premium support system (Romney’s plan) or maintaining the current system and finding other ways to reduce costs and make health care delivery more efficient (Obama’s plan) would be more advantageous for the economy and beneficiaries. However, health care experts seem to agree that the political debate is clouding the issue at best (Adamopoulos, 10/9).The Boston Globe: Future Seniors May See Benefits Tied To Means TestingMitt Romney wants to save Social Security and Medicare partly by cutting benefits for higher-income recipients. President Obama also sees wealthy Americans as part of the solution but suggests instead raising their premiums or payroll taxes. The fact that both presidential candidates back some form of so-called “means testing” suggests that millions of future seniors will probably end up paying more, or getting fewer benefits — no matter who wins the White House (Kranish, 10/10).Politico: Paul Ryan Plan Not The Weapon House Dems Had ExpectedDemocrats could barely contain their glee when Mitt Romney selected Paul Ryan as his running mate in August. The Wisconsin congressman’s controversial Medicare plan would be an anvil around the necks of Republicans nationwide, they insisted — a “majority maker” for the party, in the words of Democratic Congressional Campaign Committee Chairman Steve Israel. Two months later, that’s turned out to be mostly wishful thinking (Isenstadt, 10/9).WNYC: NJ Poll Shows Mixed Views On Health Care IssuesA majority of New Jersey voters supports President Barack Obama’s health care reforms, wants Medicare to stay as is and wants the state to expand Medicaid, according to a new poll commissioned by WNYC’s The Brian Lehrer Show. The poll conducted by the Eagleton Center for Public Interest Polling at Rutgers University found nearly six in 10 voters support the Supreme Court’s decision upholding “Obamacare.” Even larger numbers of New Jerseyans support Medicare, with only 25 percent supporting the kind of privatization that Republican challenger Mitt Romney supports (Solomon, 10/10). Campaign Buzz: Obama, Romney Vie For Swing Voters This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.last_img read more

As Congress Ponders Spending Cuts Health Care Industry Advocates Urge Medicare Be

first_img This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Congress returns today and begins efforts to negotiate a budget deal that would avert the “fiscal cliff” of automatic spending cuts and tax increases, which are slated to take effect early next year.Politico Pro: AHA To Hill: No Cuts Worse Than The SequesterThe hospital industry is worried it’s going to be called upon again to withstand funding cuts as lawmakers try to prevent this winter’s sequestration and the planned cut to physician payments. In an interview with POLITICO, top officials at the American Hospital Association say they’re concerned that the decisions being made today aren’t based on what’s best for health care, but rather what’s going to generate the most revenue savings (Haberkorn, 11/12).The Hill: Nursing Homes To Congress: Stop Looming Medicare CutsNursing homes are welcoming Congress back with a campaign against the sequester’s looming cuts to Medicare. The American Health Care Association (AHCA) will run ads against the cuts in Beltway publications and on major cable networks starting Monday. … “The end of the year marks the end of the line for sequestration. Something must be done to address these deep cuts to Medicare,” said Mark Parkinson, AHCA president and CEO, in a statement. The AHCA represents nursing homes and other skilled nursing facilities, which rely heavily on Medicare and Medicaid (Viebeck, 11/12).The Hill: Budget-Cutters Eye Health Care Law’s Insurance SubsidiesAs the election fades into the rearview mirror and attention turns more seriously toward the looming “fiscal cliff,” lobbyists and advocates are once again wondering whether Congress might look to the healthcare law for spending cuts. Specifically, lawmakers might be tempted to tap the health law’s insurance subsidies, by far its most expensive provision, and probably the most tangible benefit it will provide. Cutting into the subsidies has been discussed before, but it’s gaining new urgency as the fiscal cliff, a combination of spending cuts and tax increases set to take effect at the end of the year, draws closer (Baker, 11/12).CQ HealthBeat: Hill Pokes At Health Care Issues Before Returning For Heavy Helping Of MedicareCongress will take a crack at a few health care issues this week before recessing Friday and returning after Thanksgiving for a month of legislating — which could include cuts to a wide range of Medicare providers. On tap late Tuesday is a House vote on a measure to allow the continuing sale of existing inventories of certain inhalers to treat asthma. These epinephrine inhalers contain aerosol propellants that violate chlorofluorocarbon limits put on the law books to reduce ozone that contributes to global warming. … The week also will include consideration of Medicare payments to foster the adoption of health information technology (Reichard, 11/12).Medpage Today: Medicare Changes Likely Soon, Experts SayAs the dust continues to settle after Tuesday’s election and policy wonks debate what it means for the future of healthcare, an increasing number of experts say Medicare will be the subject of likely reforms in the near future. In post-election Washington, lawmakers and the president face what is commonly called the “fiscal cliff” — a series of expiring tax breaks, needed federal spending bills, and a periodic increase in the nation’s debt ceiling all coming together at once (Pittman, 11/9). As Congress Ponders Spending Cuts, Health Care Industry, Advocates Urge Medicare Be Sparedlast_img read more

State Roundup Calif Hires Consumer Group To Help Review Coverage Rates

first_imgState Roundup: Calif. Hires Consumer Group To Help Review Coverage Rates A selection of health policy stories from California, Connecticut, Louisiana, New Jersey, Florida and Pennsylvania.Los Angeles Times: State Hires Consumer Group To Help It Review Health Care RatesCalifornia Insurance Commissioner Dave Jones lashed out Tuesday at another double-digit rate hike for thousands of small businesses getting their health insurance from industry giant Anthem Blue Cross (Terhune, 4/3).CT Mirror: In Gun Bill, Boosts In Coverage For Mental Health, Substance AbuseThey’re not as eye-catching as the expanded assault weapons ban or a new restriction on large-capacity magazines. But the bipartisan agreement legislative leaders crafted in response to the massacre at Sandy Hook Elementary School also includes changes to insurance laws agreed to by both health plans and patient advocates. And they say the provisions will reduce barriers to treatment for people with private coverage. The changes include requiring insurers to make faster decisions about whether certain urgent mental health and substance-abuse services will be covered, and making it easier for consumers to see what criteria carriers use in determining if care is covered (Becker, 4/2).The Associated Press/Washington Post: Medicaid Contractor Objects To Cancellation, Says Nothing Improper Done to Get La. ContractThe company whose nearly $200 million Medicaid contract with the state has been cancelled says it didn’t do anything improper to get the work, despite an ongoing federal investigation into the contract award (4/2).Kaiser Health News: In South Jersey, New Options For Primary Care Are Slow To Take HoldCamden, N.J., has serious health problems, with too many people going to local emergency rooms unnecessarily. But progress is being made, albeit slowly (English, 4/3).Health News Florida: ‘Bold’ Plan Would Replace LawsuitsImagine a medical-malpractice system that resolves patients’ complaints of harm quickly, without rancor or legal fees. Imagine a system that would encourage the injured patient and doctors to discuss the event to reduce the risk of future mistakes (Gentry, 4/2).Pittsburgh Post-Gazette: SEIU Sues Pa. To Block Merging Rural Health CentersA state plan to close and consolidate rural health centers will hurt public health and leave under-served, uninsured or immigrant Pennsylvanians with fewer health care options, the union representing nurses at those centers alleges. … A lawsuit filed Monday in Commonwealth Court by SEIU Healthcare Pennsylvania asks the court to halt the cuts. Several Democratic state legislators, including Sen. Tim Solobay, D-Canonsburg; Rep. Pam Snyder, D-Jefferson; and Rep. Ted Harhai, D-Westmoreland, also are plaintiffs in the suit (Giammarize, 4/3).California Healthline: Spring Recess Gives Way To Spring WorkThe California Legislature yesterday returned to work after a 10-day spring recess. A small mountain of bills is in front of lawmakers who have until May 31 to pass bills off the floor. Health care legislation up for discussion includes: Medi-Cal simplification. … Scope of practice expansion. … More [medical] interpreters. … Tax on soda. … Race evaluation (Gorn, 4/2). This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.last_img read more

Consumers Urged To Give Healthcaregov Another Try — Just Not Too Many

first_img This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Health and Human Services Secretary Kathleen Sebelius said Tuesday that healthcare.gov is “improved every day.” But the administration delayed a big marketing campaign planned for December and is asking allies to hold back their enrollment pushes to avoid a crush of new users that might overwhelm the site again. Meanwhile, Politico reports that enrollment successes in some states show the law could work.The New York Times: A Plea To Avoid Crush Of Users At Health SiteWhite House officials, fearful that the federal health care website may again be overwhelmed this weekend, have urged their allies to hold back enrollment efforts so the insurance marketplace does not collapse under a crush of new users. At the same time, administration officials said Tuesday that they had decided not to inaugurate a big health care marketing campaign planned for December out of concern that it might drive too many people to the still-fragile HealthCare.gov (Shear and Pear, 11/26).The Wall Street Journal: Health Website Deadline NearsWith the clock ticking toward a Saturday deadline, Obama administration officials promise that the HealthCare.gov website will work better. Exactly how much better? That is hard to say. The measure of success, repeated by an array of administration officials, is that the online marketplace intended to be used by millions of Americans to obtain health insurance would be working smoothly for the “vast majority of users” by Saturday, the last day of November (Nelson, 11/26).Politico: State Successes Show Health Law Can WorkWith all the waves of bad news about the Obamacare website and the canceled policies, it would be easy to conclude that nothing in this law will ever work — that it’s just too big and complicated and messy. But that’s not the complete picture of the Affordable Care Act rollout. There are a few bright spots — just enough to suggest that, for all the early disasters, the law’s fate isn’t final yet. There are states that are running their own websites and enrolling a lot of people, way more than the amateur-hour federal website that serves most of the states. Medicaid enrollment, another part of the law, is going significantly better than the signups for private insurance — nearly 400,000 people were determined to be eligible in October (Nather, 11/27).USA Today: Sebelius: Health Site Experience ‘Improved Every Day’State and local elected officials should “not hesitate” to tell their constituents to go to HealthCare.gov and sign up, Health and Human Services Secretary Kathleen Sebelius said Tuesday. “We are definitely on track to have a significantly different user experience by the end of this month,” Sebelius said. “But this isn’t a magic turn-on switch. The experience is improved every day” (Kennedy, 11/26).CNN: Sebelius: Obamacare Website Improvements ‘On Track’ With just days to go until a self-imposed deadline, fixes to the problem-plagued Obamacare website are “definitely on track,” Health Secretary Kathleen Sebelius said Tuesday. In a conference call with state and local officials, Sebelius added that “this isn’t a magic ‘turn on the on switch'” to fix HealthCare.gov, but a continual process in which “the experience is vastly improved each and every day” (Cohen, 11/26).The Associated Press: Health Law’s Spanish Sign Up-Up Tools DelayedAdd one more delay to the list for the rollout of President Barack Obama’s health care law. This time, it’s a postponement of the launch of online enrollment tools in Spanish (Johnson, 11/26).Meanwhile, CBS News reports that the contractor responsible for the financial management part of the new marketplace was hired without bids–CBS News: Obamacare Agency Rushed In Contractor Without Bids, Documents Show Caught flat-footed by the challenges of building the financial-management and accounting parts of the U.S. government’s new online marketplace for health insurance, officials rushed to hire a familiar contractor without seeking competing bids, according to government procurement documents reviewed by Reuters. The documents dated in August — less than two months before the opening of online marketplaces established by President Barack Obama’s landmark healthcare law — showed the agency in charge had only “recently learned” that building the financial management functions was “beyond (its) currently available resources” (11/26). Consumers Urged To Give Healthcare.gov Another Try — Just Not Too Many Of Themlast_img read more

Public Health Issues Climate Change Funding For Alzheimers Research

first_imgPublic Health Issues: Climate Change; Funding For Alzheimer’s Research This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. A medical expert calls for hospitals and health care officials to begin to plan for global warming problems, and The Wall Street Journal looks at new ways to finance research.Kaiser Health News: Health Care System Needs To Prepare For Global WarmingClimate change is happening, and with that will come more deaths from heat-related illness and disease, according to a report released Tuesday. “One of the most striking findings in our analysis is that increasing heat and humidity in some parts of the country could lead to outside conditions that are literally unbearable to humans, who must maintain a skin temperature below 95°F in order to effectively cool down and avoid fatal heat stroke,” the report’s authors wrote. … Dr. Al Sommer, the dean emeritus of the Bloomberg School of Public Health at Johns Hopkins University in Baltimore, was on the committee that oversaw the development of the report. He says that often overlooked in the current debate about greenhouse gases and climate change is the effect of global warming on individuals and hospitals” (Gillespie, 6/26).The Wall Street Journal: Should Alzheimer’s Bonds Be Issued To Fund Drug Development? The quest for a treatment that can combat Alzheimer’s remains frustrating and expensive, but Andrew Lo believes he may have a path forward. A finance professor who directs the Laboratory for Financial Engineering at the MIT Sloan School of Management, Lo thinks that a public-private partnership could solve some of the funding issues that have plagued drug discovery and development. The plan, which he recently discussed in a paper in Science Translational Medicine, is to create what the pharmaceutical world likes to call ‘lots of shots on goal.’ We spoke with Lo about his idea (Silverman, 6/25).Meanwhile, entrepreneurs express optimism about harnessing health data to create new patient tools -CQ Healthbeat:  Tech Companies, Congress Look to Health Data to Create New Patient ToolsSilicon Valley entrepreneur Anne Wojcicki had to halt sales of her company’s genetic tests for medical uses last year after the Food and Drug Administration voiced concerns over how the data would be used and its accuracy. That experience hasn’t soured Wojcicki’s outlook on the role that the government may play going forward in transforming a growing wealth of data into practical tools for improving the health of Americans. In fact, in a Tuesday interview, she was enthusiastic about the steps that officials within the Department of Health and Human Services are taking to make personal health information and broader health trends accessible (Young, 6/25). last_img read more

What is 8K TV Is it the future of TV tech in

first_img We’d also like to send you special offers and news just by email from other carefully selected companies we think you might like. Your personal details will not be shared with those companies – we send the emails and you can unsubscribe at any time. Please tick here if you are happy to receive these messages.By submitting your information, you agree to the Terms & Conditions and Privacy & Cookies Policy. Heard the buzz about 8K TV and wondering what all the fuss is about? We’ve got all the details you need to know about the next big TV resolutionNext-gen resolution is looking like the biggest news of not only this year but upcoming ones too. With the first 8K displays making it to market at the end of 2018, most TV manufacturers will launch their first 8K wares over the course of 2019.But is 8K something that you should care about right now? We’ve broken down everything you need to know about TV’s next big thing.Related: Best TV dealsWhat is 8K and why should I care about 8K TV?When we talk about 8K, we’re talking about the resolution of the screen, which equates to the number of horizontal and vertical pixels that a screen can display.The more pixels of an image we see, the better quality the image should be, as you’re getting more of the finer detail that lesser screens gloss over.With 8K TV, you get a total resolution of 7680 pixels horizontally and 4320 pixels vertically – four times the pixels you get with 4K (2840 x 2160) and 16 times that of Full HD (1920 x 1080). That’s a jump from the 8 million of pixels in 4K to around 33 million pixels.4K vs 8K: Isn’t 4K enough?4K is superb, and if you haven’t upgraded your home TV to 4K yet, you’ll be amazed at the differences between 4K HDR content and Full HD. In theory, 8K will offer a similar leap.The differences might not be quite as stark, but when you’re looking to get the most immersive experience possible, the more detail you can pack into a shot, the better.In practical terms, it’s the difference between looking at an 8-megapixel picture and a 33-megapixel picture – with an HD picture being just 2 megapixels by comparison. For the naysayers doubting whether those extra pixels will be worth it, we’ve seen it up close and it does make a dramatic difference to the quality of the picture.What 8K TVs are available?Sony’s KD-85ZG9 8K TVManufacturers have been talking about 8K before 4K was even really established, but 2018 was the year when things started to heat up.Sharp produced its first 8K TV back in 2015 in the £100,000, 85-inch LV-85001 for the Japanese market, and for a few years that was the only 8K TV on the market. It was only when familiar household manufacturers like LG, Samsung and Sony began showcasing consumer-facing sets that industry interest was piqued.Unbelievably, the Samsung Q900R came to market at the end of 2018. The South Korean manufacturer swiftly followed that up with the Q950R in the early knockings of 2019 which offered stunning images.LG’s mammoth 88in OLED 8K (OLED88Z9PUA) appeared at trade shows in 2018, and it is the first 8K OLED screen of its kind. It went on sale (June) in South Korea, with the US and Europe expected to receive the 8K TV in the third quarter of 2019.Toshiba and Sony previewed concept 8K sets at recent trade shows, but the latter beat the former to the punch with its KD-85ZG9 8K TV which launched in the UK in June 2019. The Sony KD-98ZG9 doesn’t have a release date yet, but is expected to arrive in 2019.Related: Sony KD-85ZG9 reviewHow much with an 8K TV cost?For the 85-inch model, Samsung’s Q900R was initially available for £15,000. That wasn’t unexpected, considering how new the technology is. We expect 8K TVs to become cheaper with each generation and that logic has followed with Samsung’s 2nd-gen Q950R costing £10,000.The 75- and 65-inch versions sell for £6,999 and £4,999 respectively. Again, while it’s cheaper, that’s not strictly affordable for many people.LG’s OLED88Z9PUA 8K OLED is available for pre-order, but suffice to say you’ll need deep pockets for it. Pre-orders have it listed at nearly £30,000. And that’s just the early bird price to attract pre-orders.Sony eschewed OLED for LED with its KD-85ZG9 8K TV. It’s available for a snip at £14,000, which brings it in line with Samsung’s first-generation effort. Hopefully if Sony produce another, the price will come down further.The 98-in version is likely a different matter altogether. A bigger screen means more pixels and requires more backlight zones to produce that image. You’ll need to take out a mortgage for the KD-98ZG9, as it costs an eye-watering £85,000.Does 8K need a big screen?The average size of TVs has been shifting upwards in recent years. That’s down to a combination of reduced prices, improved design, and higher quality picture resolution.As screens get larger, pixel density decreases, so higher resolutions make more sense on bigger TVs.That explains why the majority of  8K demos have been shown on screens of 80-inches and above, although as we’ve mentioned, Samsung has 8K TVs available in a more accessible 65 inches – which are much more living room friendly.What can I watch in 8K?Long story short? There’s very little, if any, native 8K content right now.Japan (where else?) ran 8K demo broadcasts on its public TV channel NHK back in 2016 and subsequently launched a dedicated 8K TV channel in late 2018. This will be the channel where Tokyo’s 2020 Olympic Games will be broadcasted in the format.The public broadcaster also has showrooms dotted around to show off the might of 8K, securing an exclusive version of Stanley Kubrick’s 2001: A Space Odyssey, scanned by Warner Bros., in 8K.Brazil even showed some of the 2018 World Cup in 8K at Rio de Janeiro’s science museum. The tech support required to make it happen was far from straightforward, so it’s not exactly ready for mass consumption just yet. Rakuten is aiming to launch an 8K service by the end of 2019, although what native content it will have remains unknown for now.From a film perspective, Hollywood has already dipped its toe in the water with 8K – just as it started with 4K long before it was a ‘thing’.Guardians of the Galaxy vol.2In fact, the first 8K shoot is already in the can. 2017’s Guardians of the Galaxy Vol. 2 was the first to be shot on RED’s 8K Vista Vision camera, but was downscaled for its cinema release.Films shot in 15/70mm IMAX are thought to have a resolution of 12K, so there is potential for 8K content. It’s more a question of building the infrastructure to support transmission of 8K content, and in turn make it a viable proposition for consumers.There’s also formats like VR to think about. The £4200 GoPro Omni VR might not be in many budgets, but it is capable of shooting at an 8K 30 fps spherical resolution for VR. The Insta360 Pro camera offers similar virtual reality shooting, while the long-rumoured Apple AR/VR headset is thought to be packing dual 8K displays – one for each eye.Gaming isn’t one for lagging behind the curve, either, with a plethora of YouTube videos showing 8K–- and, whisper it, even 16K – gaming rigs. The Dell Canvas UP3218K gaming monitor is 8K capable, but the hardware to make it happen is slightly more complicated.A Thirty IR Witcher III playthrough in 8K last year required four Nvidia GTX Titan Xp graphics cards costing $1200 each to achieve – and that’s before you even get to the processor and memory required. Hardly a hobby, for now at least.In 2020 the expectation is the next generation of home gaming consoles will feature support for 8K video.Sony’s Mark Cerny – the lead system architect on the PS4 – confirmed that the PS5 (or whatever it’s going to be called) will support 8K graphics. We guess that won’t mean native 8K content, rather the upscaling of content to 8K. Whatever the case, it opens up the need to purchase an 8K display.Related: PS5 latest news – release date, price, games, rumours and specsWhat else is happening right now? What is 8K TV upscaling?With so little content currently available, 8K right now is mainly about upscaling. From what we’ve seen, the results can be pretty impressive.For example, Samsung’s Q950R uses the company’s new Quantum Processor 8K chip, which uses ‘AI upscaling’ to boost lower-res footage to 8K.It uses complex algorithms to recognise patterns in images and calculate the extra pixels required to fill in the gaps that 4K (or even HD) is missing. The chip uses a huge image database, which Samsung says will be constantly updated to keep it as accurate as possible.Sony uses its vast experience in the upscaling arena to bring non-8k pictures up to standard. Searching its 8K database for reference images, it can also call upon native 8K content from its Sony Pictures film studio and information from its Sony Cinealta cameras to help inform what 8K content should look.That data, along with the KD-85ZG9’s X-Reality Pro upscaling engine and the X1 Ultimate Processor, work together to create what is on the screen.8K vs 4K TVs: Should I buy a 4K TV or wait for 8K?That’s the big question and, for now at least, the answer is pretty clear cut.As there’s no true 8K content yet, you’d only really be buying an 8K TV for bragging rights and to get a glimpse of its potential via upscaling – we’re still a long way from seeing 8K hit the mainstream. After all, despite a few more 8K TVs going on sale, they’re still pretty expensive.Related: Best 4K TVsWhile 4K is still far from being ubiquitous, the amount of investment in the technology by major broadcast networks, film studios and companies makes it unlikely it will be usurped any time soon in the consumer market.Those wanting to get the most out of their TV viewing experience right now should buy 4K – whether it’s an upgrade from Full HD or a ‘good to great’ 4K swap. There are loads of fine affordable options out there, like the Hisense A6200. If you go higher, you can splurge on a high-end Ultra HD set in the Samsung Q90R or LG C9 OLED.The 8K vs 4K TV battle may be in its early throes, but buying a quality 4K TV will serve you well for some time yet and comes as our recommendation for most people. Sign up for the Mobile NewsletterSign Up Please keep me up to date with special offers and news from Goodtoknow and other brands operated by TI Media Limited via email. You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Show More Unlike other sites, we thoroughly review everything we recommend. We use industry standard tests to evaluate products in order to assess them properly. We’ll always tell you what we find. Trusted Reviews may get a commission if you buy through our links. Tell us what you think.last_img read more

Gears 5 is having two multiplayer technical tests this month on Xbox

first_img Sign up for the Mobile NewsletterSign Up Please keep me up to date with special offers and news from Goodtoknow and other brands operated by TI Media Limited via email. You can unsubscribe at any time. We’d also like to send you special offers and news just by email from other carefully selected companies we think you might like. Your personal details will not be shared with those companies – we send the emails and you can unsubscribe at any time. Please tick here if you are happy to receive these messages.By submitting your information, you agree to the Terms & Conditions and Privacy & Cookies Policy. Weekend test sessions will be held to let players play Arcade, Escalation, and King of the Hill multiplayer modes. Arcade is a “new and approachable” multiplayer mode, Escalation is a more competitive option and King of the Hill is a long-term fan favourite.There are two tests planned, with the first taking place from July 19 until July 21, while the second is available from July 26 through July 29. They’ll be open to anyone that has pre-ordered Gears 5 from a participating retailer or digitally, or players with an Xbox Game Pass membership. You’ll be able to download the technical test client at any point from July 17 until July 29 on your Xbox One or Windows 10 PC, but the servers will only actually be live during the specified weekends. Related: Best Xbox One GamesIn addition, the technical test will include a training mode — Bootcamp — which should help curious newcomers learn the ropes, although the multiplayer test weekend is likely to be a fairly bruising experience for new players. There’s also a short “Tour of Duty”, a series of challenges that can allow players to earn content for the game: completing all of the challenges will give tech test players an exclusive Tech Test Banner, but also three weapon skins for use in the Versus game mode.Gears of War on PC is a bit of a treat, too. The franchise has something distinct to it compared to several other multiplayer shooters, so I’ll likely dip in myself, despite the fact I’ll likely get completely battered. Microsoft has provided more information in a blog post, which also points out that you might experience some issues with the technical test because it is, well, it’s a test. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.center_img Show More Unlike other sites, we thoroughly review everything we recommend, using industry standard tests to evaluate products. We’ll always tell you what we find. We may get a commission if you buy via our price links.Tell us what you think – email the Editor Gears 5 isn’t arriving until September, but eager fans will be able to get their hands on Microsoft’s latest shooter with a Versus Multiplayer Technical Test, taking place in July. last_img read more

Gluskin Sheff shares soar in wake of 445 million deal with Onex

first_img 0 Comments advertisement Comment March 25, 201911:55 AM EDTLast UpdatedMarch 25, 201912:59 PM EDT Filed under News FP Street Facebook Gerry Schwartz, chairman and chief executive of Onex.Galit Rodan/Bloomberg Reddit ← Previous Next → Gluskin Sheff shares soar in wake of $445 million deal with Onex Wealth manager signs deal to be acquired by private equity firm Onex Email What you need to know about passing the family cottage to the next generationcenter_img More TORONTO — Shares in Gluskin Sheff + Associates Inc. soared nearly 30 per cent after the company signed a deal to be acquired by private equity firm Onex Corp. worth $445 million.Gluskin Sheff shares were up $3.18 at $14.35 in trading on the Toronto Stock Exchange late Monday morning.Onex announced its friendly offer for Gluskin Sheff of $14.25 per share after the close of markets on Friday.Onex chairman and chief executive Gerry Schwartz called Gluskin Sheff one of the largest and most respected independent wealth management firms in Canada.Under the agreement, Gluskin Sheff will continue to be led by its existing leadership team and operate under its brand.The deal, which requires regulatory, shareholder and court approvals and well as the satisfaction of customary closing conditions, is expected to close in the first half of 2019.Related Stories:Onex’s WestJet buyout gets nod from Transport Minister  Twitter Recommended For YouBOJ Kuroda keeps upbeat view on economy, hints steady policy this monthRothschild buys minority stake in equity research firm RedburnSterling weakens for a third day as hard Brexit fears riseCzech yields mixed before euro-denominated bond sale, FX downStocks fall on U.S.-China trade woes; FX slides The Canadian Press Join the conversation → Sponsored By: Featured Stories Share this storyGluskin Sheff shares soar in wake of $445 million deal with Onex Tumblr Pinterest Google+ LinkedIn last_img read more

RBC hikes dividend as earnings rise in challenging market conditions

first_img February 22, 20197:23 AM EST Filed under News FP Street What you need to know about passing the family cottage to the next generation Reuters TORONTO — Royal Bank of Canada on Friday reported a 7 per cent rise in earnings in the first quarter, with growth in personal and commercial banking partially offset by lower earnings at its capital markets division.Canada’s biggest lender by market value said earnings per share rose to $2.15 in the three months to Jan. 31. Adjusted earnings per share were $2.19, in line with analysts’ expectations, according to IBES data from Refinitiv.The Toronto-based lender hiked its quarterly payment to common shareholders by four cents to $1.02 per share.Chief Executive Dave McKay said the bank had delivered solid results against a challenging market backdrop.The bank said net income rose 5 per cent to $3.17 billion during the period. That included growth of 3 per cent at its personal and commercial banking business, helped by increased sales and improved margins thanks to higher Canadian interest rates. Like other Canadian banks, RBC has benefited from the Bank of Canada raising rates five times since July 2017.The bank said net income at its capital markets division declined by 13 per cent during the period due to an increase in funds set aside to cover bad loans and a decline in revenue from corporate and investment banking due to challenging market conditions. Global stock markets declined during the period due to investor concerns about rising interest rates and escalating trade tensions between the U.S. and China.Net income at the bank’s wealth management business was unchanged from a year ago, RBC said, with increased sales offset by higher costs and increases in funds set aside to cover bad loans. Net income at the bank’s insurance business rose by 31 per cent from a year ago, partly reflecting lower claims costs.With files from Canadian Press© Thomson Reuters 2019Correction: An earlier version of this story incorrectly said earnings rose two per cent.  Comment RBC hikes dividend as earnings rise in challenging market conditions Profit at capital markets division declined by 13 per cent 0 Comments Facebook Email Twitter RBC Chief Executive Dave McKay said the bank had delivered solid results against a challenging market backdrop.Canadian Press center_img ← Previous Next → Recommended For YouFar from over: euro zone bond rally regains momentumIndian govt seeks to tap foreign lenders for loans to its small firms-sourcesEU sets out first stress test for money market fundsSchlumberger names Olivier Le Peuch CEO, replacing KibsgaardIndian utilities’ coal imports in H119 rise over 53% from year ago Join the conversation → Share this storyRBC hikes dividend as earnings rise in challenging market conditions Tumblr Pinterest Google+ LinkedIn Featured Stories Reddit Sponsored By: More advertisementlast_img read more

Tesla launches big delivery event for Model 3 deliveries as it changes

Tesla is holding a big two-day delivery event at its delivery center in Fremont this weekend. The event marks a change in the automaker’s usual custom-made production and delivery strategy.The good news for Model 3 owners is that some of them are getting early deliveries. more… Source: Charge Forward

Fastned Fast Charging In The Lens Of Fully Charged Video

first_img HUBER+SUHNER Confirms Correct Functionality Of Charging Cables/Plugs Fastned expands to Germany, hopes to install 1,000 stations in EuropeFully Charged once again featured Dutch fast charging network – Fastned, which is one of the best operators in terms of approach (multi chargers stations, up to 175 kW) and reliability.The good thing at Fastned is also high visibility of the stations and a roof (with some solar cells embedded for additional power), really appreciated when the weather is not so good.“Although we’ve previously covered the Fastned Network in the Netherlands, they are moving ahead with the technology (175 kilowatt chargers) and the area they cover. There are Fastned charging stations opening soon in Newcastle and Sunderland in the UK. And they look wonderful and are easy to spot as you drive along.” Fastned is currently expanding its network beyond the Netherlands – almost 10 stations were opened in Germany. Long term ambitions reach 1,000 fast charging stations in Europe (compared to less than 90 already installed).Fastned currently doesn’t see much need for energy storage systems at sites, because usually, it has plenty of power from the strong grid, but when the stations will be bigger, like 20 ultra-fast chargers at one site, it’s will be a must to handle peak demand. Tesla Now Operates Over 12,000 Superchargers At 1,400 Stations Tesla To Offer CCS Adapter For Model S, X In Europecenter_img Fast charging news Source: Electric Vehicle News Author Liberty Access TechnologiesPosted on February 7, 2019Categories Electric Vehicle Newslast_img read more

ONYX is bringing mopeds back in style with USbuilt 60 mph electric

first_imgIn their heyday during the 70’s and 80’s, mopeds were one of the coolest ways to get around. The feel of a motorcycle, yet as manageable as a bicycle (and without the need for a moto license), mopeds were the ultimate freedom vehicle. With most reaching speeds of 30 mph (48 km/h) stock, yet tunable to higher speeds, mopeds were seen as a fast and efficient way to get around. But with the unyielding march of time, mopeds eventually went the way of the mullet and the 8-track.Until now, that is. San Francisco-based ONYX Motorbikes is bringing mopeds back in style, with a twist. This time, mopeds are going electric! more…The post ONYX is bringing mopeds back in style with US-built 60 mph electric bikes appeared first on Electrek. Source: Charge Forwardlast_img read more

Ubers electric bicycles are starting to get more riders than their cars

first_imgSource: Charge Forward The shared electric bicycle and scooter market is still undergoing explosive growth. With tens of millions of rides across just a few large industry players, there is every incentive for companies to grow their electric scooter and bicycle sharing operations quickly.Uber-owned Jump has managed to secure its own fair share of the booming market. In fact, Jump is beginning to score more electric bicycle riders than Uber’s own ridesharing cars. more…The post Uber’s electric bicycles are starting to get more riders than their cars appeared first on Electrek.last_img read more

Save 500 off Ryobis electric zeroturn riding lawn mower more in todays

first_imgSource: Charge Forward Home Depot offers the Ryobi 42-inch 100Ah Electric Zero Turn Riding Lawn Mower for $3,599 shipped. That’s good for $500 off and a match of the best we’ve seen. This Ryobi riding mower reimagines your lawn cutting experience with a fully battery-powered design that can cut up to 3 acres on a single charge. Features include a 42-inch steel deck, 12-position adjustment, side or mulching discharge and it even has a USB port for charging your device. Rated 4.9/5 stars. More below. more…Subscribe to Electrek on YouTube for exclusive videos and subscribe to the podcast.https://www.youtube.com/watch?v=V1zk7Eb8r-s&list=PL_Qf0A10763mA7Byw9ncZqxjke6Gjz0MtThe post Save $500 off Ryobi’s electric zero-turn riding lawn mower, more in today’s Green Deals appeared first on Electrek.last_img read more

New computerized test could lead to earlier and efficient ADHD diagnoses

first_imgMay 4 2018The prevalence of attention deficit hyperactivity disorder (ADHD) diagnoses in children and young people has increased, but diagnostic practice among clinicians remains variable, with significant diagnostic delays and reliance on subjective assessments. A new clinical trial published in the Journal of Child Psychology and Psychiatry shows that adding a computerized test of attention and activity (QbTest) to standard care can reduce the time needed to make a diagnostic decision on ADHD, increase the likelihood of excluding ADHD when it is not present, and improve clinicians’ confidence in their decision-making, without compromising diagnostic accuracy.In the randomized, parallel, single-blind controlled trial in mental health and community paediatric clinics in England (the AQUA study), 267 participants aged 6-17 years-old and their clinician were randomized to either receive the QbTest report or not as part of their standard diagnostic assessment for ADHD. 132 out of the 267 participants and their clinicians received the QbTest report.Clinicians with access to the QbTest report were more likely to reach a diagnostic decision about ADHD. At 6 months, 76% of those with a QbTest report had received a diagnostic decision, compared with 50% without. The QbTest reduced appointment length by 15%, increased clinicians’ confidence in their diagnostic decisions, and doubled the likelihood of excluding ADHD. There was no difference in diagnostic accuracy.The prevalence of attention deficit hyperactivity disorder (ADHD) diagnoses in children and young people has increased, but diagnostic practice among clinicians remains variable, with significant diagnostic delays and reliance on subjective assessments.Related StoriesInternational study aims to more accurately describe mental health disordersGuidelines to help children develop healthy habits early in lifeNew network for children and youth with special health care needs seeks to improve systems of careThe AQUA study, published in the Journal of Child Psychology and Psychiatry, was funded by the NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands and supported by NIHR Mental Health MedTech Co-operative.”The assessment of ADHD remains largely subjective and children and young people in the UK, compared to other European countries, experience some of the longest delays for a diagnostic decision and initiation of appropriate treatment,” said lead author Professor Chris Hollis, of the University of Nottingham, in the UK.”The AQUA trial is ground-breaking because it is the first independent randomized-controlled study to demonstrate that an objective assessment technology (QbTest) can increase the speed and efficiency of diagnostic decision-making in ADHD. The clinicians who had access to a QbTest report were faster in reaching diagnostic decisions with no overall loss of diagnostic accuracy.”Interestingly, clinicians with a QbTest report were more likely than those without a QbTest report on a young person to exclude a diagnosis of ADHD. The results suggest that QbTest is ready for implementation within the ADHD assessment pathway in the UK, and other countries with similarly long delays to diagnosis, where it is likely to lead to earlier diagnostic decisions and significant healthcare system efficiencies.” Source:http://newsroom.wiley.com/press-release/computerized-test-may-help-improve-adhd-diagnoseslast_img read more

HPV vaccine for girls gets thumbs up from Cochrane review

first_imgBy Dr. Ananya Mandal, MDMay 13 2018According to a Cochrane review that was released recently, the HPV vaccine, that can protect girls and young women from Human Papilloma virus (HPV) can help protect them against cancer of the cervix later in life. The report appears in the latest issue of the Cochrane Database of Systematic Reviews.The review by Dr. Marc Arbyn of the Unit of Cancer Epidemiology at the Belgian Cancer Centre in Brussels, and colleagues looked at 26 studies to see the effects of HPV vaccination on cervical pre-cancerous lesions. The results revealed that women who were initially negative for hrHPV or HPV 16/18 DNA had a lesser chance of getting these precancerous lesions. Further the vaccine administered to young women and adolescent girls did not cause any serious side effects, miscarriages, stillbirths or abnormalities in the baby.Dr. Arbyn said that cervical cancer is the fourth most common cancer among women and nearly a million cases are diagnosed each year. Half a million women succumb to this cancer annually, he said.This review is unique because despite several phase 1 and phase 2 clinical trial reports with HPV, this is the first time that results from all the important studies conducted with HPV vaccine have been combined to come to a systematic conclusion. While each of these studies looked at overlapping end points, this study looked at a comprehensive list of endpoints wrote the researchers. Authors hope that this review would provide “a template for reporting future results of prophylactic vaccination trials according to the different outcomes … for different exposure groups.”Related StoriesMore effective flu vaccine begins clinical trials across the U.S.Novel vaccine against bee sting allergy successfully testedUM scientists receive $3.3 million NIH contract to develop opioid addiction vaccineThe authors state that they were specifically looking at protection of the bivalent vaccine targeting HPV 16/18. This strain is responsible for 70 percent of all cervical cancer cases. Another vaccine under their scanner was the quadrivalent vaccine that also protects against HPV infections leading to genital warts.All in all the review looked at over 73,000 participants. Among the 26 studies, 10 trials looked at the patients for an average of 1.3 to 8 years after vaccination. These checked the patients for cervical intraepithelial neoplasm and adenocarcinoma in-situ (CIN/AIS) – both early cancer stages. These studies were small and conducted for a shorter period of time wrote the researchers.They noted that when the girls and young women were hrHPV-negative at the start of the study, the vaccine lowered CIN2+ and CIN3+ and reduced risk of AIS with moderate certainty. CIN2+ associated with HPV 16/18 was also reduced with the vaccines. This was however more prominent among women aged 24 years or less. If the vaccines were administered between ages 25 and 45, they noted, the risks of CIN2+ associated with HPV 16/18 and any CIN2+ were similar between vaccinated and non-vaccinated women. They recommend vaccinating girls and women between ages 15 and 26 years for best protection.The World Health Organization recommends vaccination against HPV for girls as well as boys between ages 9 and 14. These guidelines are similar in most countries. This review looked at effects on young girls and did not explore the protective effects of the vaccine on boys.Source: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD009069.pub3/fulllast_img read more

Genetic fixeruppers could aid in predicting prognosis of patients with bladder cancer

first_img Source:http://news.psu.edu/story/521494/2018/05/14/research/genetic-fixer-uppers-may-help-predict-bladder-cancer-prognosis May 15 2018Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.The researchers found that bladder cancer patients who had mutations in their ATM or RB1 genes — proteins that help repair DNA damage when they’re functioning normally — tended not to live as long as patients without the mutations.Dr. Monika Joshi, assistant professor of medicine at Penn State Cancer Institute, said that as researchers try to design better treatments for cancer patients, it’s important for them to find biomarkers that can help researchers understand the differences between patients and their prognoses.”We’re coming to realize that not every cancer patient is the same,” Joshi said. “We see some patients responding to therapies, while others do not. Treatments like chemotherapy and immunotherapy do not have a 100 percent response rate. So we’re trying to delve deeper to better understand biological differences between patients.”According to the researchers, mutations or defects in DNA repair genes — like ATM and RB1 — play a role in tumor growth and how the cancer responds to treatment, and are often found in patients with bladder cancer.Previous research has also shown a connection between these mutated DNA repair genes and patients who respond better to certain types of chemotherapy. Joshi said this could be because the drug used in the treatment works better in cells when they’re dividing.”These genes help repair damage to the DNA, but when these genes are mutated, they actually reduce the repair response, allowing tumor cells with defective DNA to proliferate,” Joshi said. “And when those tumor cells are proliferating, at that point they may be more susceptible to certain treatments like chemotherapy.”Joshi and the other researchers wanted to better examine how ATM and RB1 genes predicted the outcomes of patients with bladder cancer and analyzed information from two separate data sets.Related StoriesSugary drinks linked to cancer finds studyResearchers identify gene mutations linked to leukemia in children with Down’s syndromeStudy: Nearly a quarter of low-risk thyroid cancer patients receive more treatment than necessaryThe first — or “discovery” – data set, included information about 130 bladder cancer patients from the Cancer Genome Atlas, a public database of cancer and genomic data. The second — or “validation” – data set, included information about 81 patients with bladder cancer or other related cancers from three academic medical centers.Mutations in the ATM or RB1 genes were found in 24 percent of patients in the discovery data set, and 22.2 percent of patients in the validation data set. Patients in both data sets with these mutations also tended not to live as long.After two years, a significant difference was observed in the discovery data set in which about 15 percent of patients with mutations were still alive as compared to 45 percent of patients without mutations. A similar (although non-statistically significant) trend was noted in the validation data set, where about 50 percent of patients with mutations were still alive as opposed to 60 percent of patients without mutations.Joshi said the results — recently published in the journal Oncotarget — bring up important questions when compared with the findings of previous studies.”It would be interesting to further study these two specific genes and see what about them may make patients fare worse,” Joshi said.While it may be discouraging for patients to discover they have a gene that may predict a poor prognosis, Joshi added that the findings also have the potential to help researchers decide where to focus their work in the future.”If we know patients with this gene have a poorer prognosis, we can focus our efforts to learn more about why this might be happening so we can improve therapies for these patients,” Joshi said. “We might not have all the answers after this study, but I think it helps pave the way for future development of targeted therapies in bladder cancer.”last_img read more

Whisks innovative Culinary Coach selected as winner of Ascensia Diabetes Challenge

first_imgRelated StoriesSome people treated for type 1 diabetes may have monogenic diabetes, study findsUranium toxicity might have caused obesity and diabetes in Kuwait, finds new studyUTHealth researchers investigate how to reduce stress-driven alcohol useThe competition also awarded two runners-up prizes. US-based Qstream were awarded a runner-up prize for their mobile learning platform that combines a concept known as spaced education with engaging game mechanics. This platform is designed to encourage meaningful behavior change and has been proven in a recent randomized trial to generate sustained and meaningful reductions in HbA1c in people with diabetes. xBird, a Germany-based medical artificial intelligence software company was also named as a runner-up. Their software analyzes micro-movements, collected by smartphones and wearables, and cross references them with historical blood glucose data, with the aim of being able to predict and detect potential hypo- and hyperglycemic events. Both runners-up will receive a cash prize of €30,000 to further develop their solutions.Walk With Path were also recognized for their highly innovative active insole for people with peripheral neuropathy due to diabetes. Their insole provides vibrational feedback during walking that can be tracked via an app and is designed to help people achieve better balance, thereby reducing the risk of falls. Ascensia will support Walk with Path to conduct a proof of concept study in patients with diabetes.Michael added: Jun 25 2018Today, at the American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management. Whisk’s solution was selected from 116 entries that were submitted to the challenge from 25 countries and they will receive a cash prize of €100,000 to build and pilot this exciting new service for people with type 2 diabetes, working closely with Ascensia Diabetes Care to bring it to patients.Whisk’s core technology uses extensive food ontology known as the Food Genome™, that incorporates and understands macro and micro-nutritional data, flavor compounds, store availability, price and promotions. Whisk is currently available in the US, UK and Australia, powering half a million shopping lists every month at grocery retailers including Walmart, Tesco and Amazon Fresh.Nick Holzherr, Whisk Founder and CEO, said: Whisk’s winning innovation is a Culinary Coach that uses artificial intelligence (AI) to provide personalized food recommendations based on flavor preferences and food avoidance, that will be expanded to use blood glucose data for people with diabetes. Later today, Whisk will be presenting their winning solution to the diabetes community for the first time at the 2018 DiabetesMine D-Data Exchange Event in Orlando.The Whisk platform is an AI-powered nutrition platform that currently enables users to browse recipes based on factors including their personal taste preferences, time constraints, budgets, weather and dietary restrictions or allergies. Once a user adds a recipe to their meal plan, it can be automatically added to an online shopping cart at some of the world’s leading grocery retailers, seamlessly allowing them to buy ingredients.As winner of the challenge, Whisk plan to create a personalized food experience for people with type 2 diabetes that will learn from their blood glucose readings and make food recommendations that are more tailored to their own diabetes. Using readings from Ascensia’s blood glucose monitoring systems, the AI will learn how the user’s blood glucose readings react to specific foods and recipes, allowing them to build a tailored meal plan for their diabetes that can help to keep their blood glucose in range. The Culinary Coach for diabetes will start by providing personalized recipe recommendations, and will in the future develop to suggest convenience foods and restaurant options.Michael Kloss, CEO and President of Ascensia Diabetes Care, said: We are absolutely delighted to have been chosen as the winner of the Ascensia Diabetes Challenge. Type 2 diabetes has reached epidemic levels in recent years, and at Whisk we are excited to be building a solution that we feel can help support these patients to make lasting lifestyle changes. We hope that through our work with Ascensia Diabetes Care, we can help to change the way this condition is managed.”center_img Source: http://www.ascensia.com/press/press-release/?id=d074e136-122e-4fc0-b99d-1b3a1a41cd18 Nutrition and food selection is a huge component of type 2 diabetes management. The panel of judges and I were hugely impressed by Whisk’s current tool and how they plan to develop it for people with type 2 diabetes. By helping people with type 2 diabetes find personalized and tailored meal recommendations that are based on their own blood glucose data and food preferences, we have the potential to empower millions of people with type 2 diabetes to make healthier food choices that they will enjoy.” We are very excited to partner with such high quality digital solutions that could help revolutionize type 2 diabetes management. These winning solutions highlight the exciting times we are now entering in the world of digital health and how technological advances and digital capabilities can play a massive part in meeting an urgent area of unmet need.”last_img read more

Study finds major discrepancies in prescription drug labeling pregnancy information across four

first_imgJul 17 2018Pregnancy Information Across Four Countries A study comparing the evidence and recommendation levels of pregnancy information in new prescription drug labeling found significant discrepancies in labeling information among the United States, the United Kingdom, Japan, and Korea. Inconsistent labeling information may hinder informed decision making and optimal patient care, according to the authors of the study published in Journal of Women’s Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women’s Health website.Related StoriesPre-pregnancy maternal obesity may affect growth of breastfeeding infantsExercise during pregnancy can promote bone health of both mother and childMaternal prepregnancy surgery linked to increased risk of opioid withdrawal in newbornsYunha Noh, PharmD and colleagues from the School of Pharmacy, Sungkyunkwan University, South Korea, selected 81 drugs approved in all four countries from 2008 to 2016 and estimated the agreement of evidence and recommendation levels of the labeling information between the countries. In the article entitled, “Discrepancies in the Evidence and Recommendation Levels of Pregnancy Information in Prescription Drug Labeling in the United States, United Kingdom, Japan, and Korea,” the researchers report that agreement in evidence levels was the lowest for US-Japan, whereas agreement in recommendation levels was the lowest for US-UK. Consistency of evidence and recommendation levels was highest for Korea-UK, indicating a substantial degree of agreement. The authors recommend efforts to provide internationally harmonized and reliable safety information to assist healthcare professionals and patients in making appropriate decisions regarding prescription drug use during pregnancy.”Drug labeling is extremely important in guiding clinical decisions about prescribing,” states Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women’s Health and Executive Director of the Virginia Commonwealth University, Richmond, VA. “The discrepancies among countries found in this study are concerning and should be addressed on a global level to better assist clinicians and patients in the safe and effective use of prescription drugs during pregnancy.” Source:https://home.liebertpub.com/news/significant-discrepancies-found-in-prescription-drug-labeling-pregnancy-information-across-four-countries/2402last_img read more

Dizziness could be an early sign of dementia finds study

first_imgImage Credit: Photographee.eu / Shutterstock Feeling dizzy or light headed when getting up from a sitting or lying down position is due to a sudden fall in the blood pressure. This is known as orthostatic hypotension or postural hypotension. This mainly occurs when the blood pools in the lower extremities and the brain is temporarily deprived of oxygenated blood causing the light headedness. Common symptoms of orthostatic hypotension are feeling weak, confused, faint and mild nausea.For this study the team of researchers recruited 11,709 people in the USA from the Atherosclerosis Risk in Communities (ARIC) study and found that they had a greater risk of getting dementia or stroke. The dizziness itself is not a symptom of any disease however. The study conducted by the American Academy of Neurology followed participants for an average of 25 years and the average age of the participants was around 54 years. None of these participants had an earlier history of a heart disease or stroke at the initiation of the study.Andreea Rawlings, lead author of the study of Johns Hopkins Bloomberg School of Public Health in Baltimore, explained that orthostatic hypotension has been associated with heart disease earlier. This study explored the connection such type of hypotension has with brain disorders like stroke and dementia. She said this association could mean that patients developing orthostatic hypotension could be monitored closely for development of dementia and stroke in future. She added that more studies are needed to confirm the theory and also investigate preventive strategies.Related StoriesA program of therapy and coping strategies works long-term for family dementia carersMetformin use linked to lower risk of dementia in African Americans with type 2 diabetesLiving a healthy lifestyle may help offset genetic risk of dementiaResults from the study showed that among the 11,709 participants, 1,068 (9.1 percent) went on to develop dementia and 842 (7.1 percent) went on to have an ischemic stroke. Ischemic stroke occurs when the blood flow to particular part of the brain gets blocked depriving the region of oxygen. Among the 552 participants who had orthostatic hypotension at the start of the study 12.5 percent developed dementia and 15.2 percent developed ischemic stroke during follow up. Among the 10,527 participants who did not have orthostatic hypotension at the start of the study 6.8 percent had an ischemic stroke and 9 percent had dementia during the follow up.Co-author Rebecca Gottesman, from Johns Hopkins explained that midlife orthostatic hypotention was never under the scanner before. Older people with orthostatic hypotension were focussed upon in connection with stroke, dementia and heart disease.Dementia UK’s chief executive and chief admiral nurse, Dr Hilda Hayo appreciated the study saying that it brings to notice that orthostatic hypotension can now be known as a potential risk factor for dementia in some individuals. Dr Shamim Quadir, research communications manager at the Stroke Association however said that orthostatic hypotension was only measured at the initiation of the study and this could be limitation of the study. Those developing orthostatic hypotension well into the study could also have been among those at high risk for dementia and stroke. He said more research would provide a deeper insight into this theory. He advised general population to get their blood pressure checked routinely.This study was funded by the National Heart, Lung and Blood Institute, the NIH, and the National Institute of Diabetes and Digestive and Kidney Diseases.Source: http://n.neurology.org/content/early/2018/07/25/WNL.0000000000006027 By Dr. Ananya Mandal, MDJul 25 2018A new study has found that people who feel dizzy when they stand up from lying down or sitting positions, are more at risk of developing dementia or stroke. The study was published in the latest issue of the journal Neurology.last_img read more

1 2 3 124